skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Case of endophthalmitis following intravitreal injections of bevacizumab

Case report

(2425) Views  (517) Full article downloads

Authors: Shinya Komori, AkirA Sawada, Tsutomu Oguni, et al

Published Date July 2010 Volume 2010:4 Pages 773 - 775
DOI: http://dx.doi.org/10.2147/OPTH.S11379

Shinya Komori1, Akira Sawada1, Tsutomu Oguni1, Kiyofumi Mochizuki1, Kiyofumi Ohkusu2

1Department of Ophthalmology, 2Department of Microbiology, Gifu University Graduate School of Medicine, Gifu, Japan

Purpose: We report a case of infectious endophthalmitis that developed after the third intravitreal injection of bevacizumab. The endophthalmitis was caused by Staphylococcus epidermidis.

Methods: Observational case series.

Results: This was a case of a 77-year-old man who had received three intravitreal injections of bevacizumab and developed infectious endophthalmitis. Polymerase chain reaction of an aqueous humor sample showed that the endophthalmitis was caused by S. epidermidis. The patient received intravitreal ceftazidime and vancomycin, and subconjunctival injection of vancomycin. After the intravitreal injections he was treated with topical levofloxacin and cefmenoxime hydrochloride, and intravenous cefpirome. Subsequently, the ocular inflammation gradually decreased and his visual acuity remained at 30/200.

Conclusions: Our findings indicate that endophthalmitis can develop after intravitreal bevacizumab injections. Polymerase chain reaction is useful for differentiation from sterile endophthalmitis.

Keywords: endophthalmitis, bevacizumab, Staphylococcus, antibiotics





 

Other articles by Dr A Sawada



Readers of this article also read:

Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Optimal management of perimenopausal depression
Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
Crystallization after intravitreal ganciclovir injection
Retinal vein occlusion: pathophysiology and treatment options
Retinal nerve fiber layer thickness in recovered and persistent amblyopia
A protocol for the retina surgeon’s safe initial intravitreal injections
Chryseobacterium indologenes peritonitis in a patient with malignant ascites
Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports